---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
sourceUrl: https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "wC/RVCiIfyp7cRGN03RNf13kfcJ0wsY5twh+ERRlZCEwm/E+0tJV3ZliPq2M4+hoNRqeP/7wPqxohW5g8AjUyCHlWArbiX9jldp7Ecce280Xti5DzHf5yjlvRvcON7nKVmghc8AhKwJ8Z9jKbKV+BKibpwq3WCXTsETfBzC0Ebce38iv8ARkXq2QoHVpO8GkgHUXg6MLAwR1GpcCbbmnRuRnsVPnUrrgGoQd4mK/FrMNiLHT7qjxMAihFmBO9n6PXjNKZYojDJcHzrxlCO4sfRT2Ftrmll5WAv2Jkle201axj9g9fSloEVsoKLGZPcKC;gCwHmxhlvBhmT9XfHOin+Q=="
---

